18/05/2023 - Research

Promising new treatment for childhood liver cancer

A preclinical study with support from the Spanish Association Against Cancer has identified a potential treatment approach for patients with hepatoblastoma, which involves combining standard chemotherapy with a drug currently undergoing clinical trials. The research was conducted using patient samples and animal and laboratory models, and has been led by Dr Josep M. Llovet, professor at the UB and group leader at IDIBAPS, and Dr Carolina Armengol, group leader at IGTP and member of CIBEREHD.

16/05/2023 - Innovation, Success Stories

Hyposfix, a new medical device to improve paediatric urological surgeries, has been developed by researchers at Germans Trias Hospital, with support from IGTP

The expertise and innovation spirit of researchers at Germans Trias Hospital's Paediatric Surgery Service has resulted in a new medical device for the treatment of hypospadias: Hyposfix, a urological separator-fixator. This device, which will be launched to market soon, is the result of an idea and a project led at Germans Trias i Pujol Research Institute (IGTP).

09/05/2023 - Campus Can Ruti, Innovation, Success Stories

CMCiB participates in the preclinical studies of Rob Surgical's surgical robot, the first one designed and manufactured in Catalonia

The centre reaches a milestone in its track-record by adding the first Good Laboratory Practice study in its portfolio where the tested product at the centre will reach clinical trials in humans in accordance with international Good Clinical Practice.

05/05/2023 - Research

New immunotherapy targeting tumour macrophages to tackle lung cancer

Researchers from the Innate Immunity group at the Germans Trias i Pujol Research Institute (IGTP) have developed a new immunotherapy based on a monoclonal antibody directed against tumour macrophages. The results obtained lay the foundations for a new treatment for patients with lung cancer, with the potential to be applied to other solid tumours. The study has been published in the journal eBioMedicine.

28/04/2023 - Campus Can Ruti, Institutional, Outreach, Success Stories

The podcast 'Un bri de ciència' explores type 1 diabetes in its second episode

The new episode of the podcast 'Un bri de ciència' is presented under the title "La diabetis tipus 1: quan la defensa t'ataca" (Type 1 diabetes: when your defences attack you). Researcher Marta Vives Pi explains the problems of autoimmune diseases, with an emphasis on type 1 diabetes.

27/04/2023 - Campus Can Ruti, Innovation, Institutional

IGTP is appointed as ‘EATRIS Expert Centre’

EATRIS, the European infrastructure for translational medicine, has appointed 7 Expert Centres, to provide high value added services historically offered by EATRIS Coordination and Support. Those expert services that are complementary to the existing laboratory research services offered by EATRIS institutions cover crucial areas such as innovation management, regulatory strategy, translational feasibility, and early health technology assessment. With 7 newly appointed Expert Centres, EATRIS will continue serving Europe's translational research efforts and growing demand for expert services.

26/04/2023 - Innovation

Four IGTP spin-offs selected in the WomenTechEU call

The European Commission has announced the results of the second WomenTechEU call, which aims to support innovative European deep-tech companies founded by women. This year, 134 women-led companies have been chosen to receive a €75,000 grant to assist with their innovation process and company growth. Among the selected companies are four spin-offs from the Germans Trias i Pujol Research Institute (IGTP). These companies represent a portion of the 20 Catalan women-led companies selected in the WomenTechEU call.

24/04/2023 - Innovation

New reproducible and minimally invasive stroke model through an endovascular approach

Researchers of the Cellular and Molecular Neurobiology (CMN) Research Group at the IGTP have developed and established a novel, reproducible and minimally invasive stroke model in pigs through an endovascular approach. The work has been conducted at the Centre for Comparative Medicine and Bioimage (CMCiB), a centre devoted to translational medicine at the very core of the Can Ruti Campus in Badalona together with the IGTP and the Germans Trias i Pujol University Hospital.

18/04/2023 - Institutional, Projects, Research

The Generalitat de Catalunya recognises 21 IGTP groups as Consolidated or Emerging Research Groups

The Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) has published the final resolution of the call for grants to support the activities of research groups in universities, centres and foundations. In this year's call, 21 IGTP groups have been recognised as Consolidated or Emerging Research Groups, 7 of which will receive funding totalling €340,000.

14/04/2023 - Research

Comprehensive genomic characterisation of malignant peripheral nerve tumour-derived lines challenges current diagnostic criteria

The Hereditary Cancer research group from the Germans Trias i Pujol Research Institute (IGTP) has led an international collaboration that has allowed the genomic characterisation of the most commonly used cell lines derived from malignant peripheral nerve sheath tumours (MPNSTs). This research has generated a detailed catalogue of genomic alterations for each cell line, which can be used to develop strategies for precision therapies. At the same time, a genomic repository has been created that is open to all researchers interested in these tumours. The work has been published in the journal iScience.